Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,975 | -26,189 | -103,121 | -65,631 | -39,662 |
| Depreciation Amortization | 1,116 | 636 | 528 | -83 | -300 |
| Income taxes - deferred | N/A | N/A | -793 | N/A | N/A |
| Accounts receivable | -263 | -52 | 110 | -63 | -109 |
| Other Working Capital | -5,972 | -8,546 | 1,681 | 994 | -6,296 |
| Other Operating Activity | 5,976 | 2,683 | 19,111 | 6,956 | 4,832 |
| Operating Cash Flow | $-52,118 | $-31,468 | $-82,484 | $-57,827 | $-41,535 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -73,460 | -102,695 | 54,112 | 20,449 | 4,426 |
| PPE Investments | -21,053 | -6,858 | -12,749 | -7,674 | -5,682 |
| Other Investing Activity | -21 | 0 | -135 | -84 | -45 |
| Investing Cash Flow | $-94,534 | $-109,553 | $41,228 | $12,691 | $-1,301 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 164,539 | 164,379 | 10,357 | 10,357 | 10,131 |
| Other Financing Activity | -28 | -15 | -52 | -39 | -26 |
| Financing Cash Flow | $164,511 | $164,364 | $10,305 | $10,318 | $10,105 |
| Beginning Cash Position | 30,629 | 30,629 | 61,580 | 61,580 | 61,580 |
| End Cash Position | 48,488 | 53,972 | 30,629 | 26,762 | 28,849 |
| Net Cash Flow | $17,859 | $23,343 | $-30,951 | $-34,818 | $-32,731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,118 | -31,468 | -82,484 | -57,827 | -41,535 |
| Capital Expenditure | -21,053 | -6,858 | -12,749 | -7,674 | -5,682 |
| Free Cash Flow | -73,171 | -38,326 | -95,233 | -65,501 | -47,217 |